Diabetes

It takes a village to manage people with diabetes, and that includes involving other professionals like diabetes educators, dieticians, and pharmacists more effectively, said Robert A. Gabbay, MD, PhD, FACP, chief medical officer of the Joslin Diabetes Center, chair of Patient-Centered Diabetes Care, and editor-in-chief of Evidence-Based Diabetes Management.

There may be some reluctance to reimburse telemedicine because there is a feeling that telemedicine costs might be added to overall cost, rather than be substituted, David Brumley, MD, MBA, senior medical director at Tufts Health Plan, explained at the 4th Annual Patient-Centered Diabetes Care Meeting, held April 7-8 in Teaneck, NJ.

Growth in retail health clinics reveals unmet medical needs for Americans who lack insurance, who cannot leave work, or who have disconnected with the health system. This growing sector of the health system is diagnosing and treating diabetes cases that would otherwise be missed.

Lonny Reisman, MD, CEO of HealthReveal, told attendees at Patient-Centered Diabetes Care that harnessing multiple disparate data sources can help physicians deliver better solutions at the point of care.

With not enough endocrinologists to go around, primary care physicians are important when it comes to caring for patients with diabetes, Albert Tzeel, MD, MHSA, FAAPL, regional medical director, senior products, Humana, said at the 4th Annual Patient-Centered Diabetes Care Meeting, held April 7-8, in Teaneck, NJ.

What we're reading, April 8, 2016: Disney demanded a soda study be withdrawn; WHO wants a reduction in the price of insulin; and hospitals need better tools to flag harmful prescription drugs.

A review of national Veterans Health Administration data has identified how the number of glucose-lowering agents used prior to insulin initiation impacts glycemic control.

Clinical pharmacy specialists impact patient care through improvements in clinical outcomes for diabetes, hypertension, and dyslipidemia via clinical interventions and promotion of medication adherence.

The warnings on labels will come after FDA reviewed long-term safety data.

While this study focused on calculating the global burden of diabetes, it comes as advocacy groups are stepping up calls for soda taxes marketing limits to rein in the effect of unhealthy food and drink on poor countries.

Carrying weight around the midsection was associated with dysfunction of the left ventricle, according to a study presented at the American College of Cardiology.

STAMPEDE was one of the first studies to suggest that patients who did not meet the traditional criteria for bariatric surgery might be candidates for treatment of type 2 diabetes, not just obesity.

The nation's top food and drug regulator enjoyed a warm welcome from colleagues on the final day of the 65th Scientific Session of the American College of Cardiology.

This week is the 4th annual Patient-Centered Diabetes Care (PCDC), co-hosted by The American Journal of Managed Care and Joslin Diabetes Center. Here we highlight the top 5 things to look forward to at this year’s meeting.

Results from the GAUSS-3 trial presented Sunday at the American College of Cardiology should be good news for Amgen, but an editorial in JAMA says the cost of evolocumab exceeds "willingness to pay" limits.

A small study of sudden out-of-hospital deaths raises questions about the quality of primary care, especially for women.

The 2013 guideline update from the American College of Cardiology and the American Heart Association drew criticism when it was presented. Data presented in today's poster session at the ACC Scientific Session revealed unexpected results.

The half-day program covered healthy eating, how to prescribe exercise, evidence about stress reduction, and other lifestyle topics, as part of the American College of Cardiology's focus on prevention.

Greetings from First Lady Michelle Obama and a lecture from a non-cardiologist on population health set the stage for the 65th Scientific Session of the American College of Cardiology. Prevention is the focus of this year's meeting.

Results from the HOPE-3 trial, presented on the opening day of the 65th Scientific Session of the American College of Cardiology, suggest cholesterol-lowering statins could have preventive benefits in broader groups of patients than previously thought.

This week, the top stories in managed care include CMS paying for diabetes prevention, coverage of the American College of Cardiology conference, and improving patient education of immunotherapy.

Researchers said the findings show the need for greater attention to treatments needs for younger patients with type 2 disease.

Sales peaked when this year's high school graduates were born, and have been declining ever since.

The cancer drug, best known as a game-changer for chronic myeloid leukemia, lowers insulin resistance through a similar mechanism as TZDs without the negative effects.

After The New York Times reported the nature of the ties between Coca-Cola and the Global Energy Balance Network, the University of Colorado returned a $1 million donation it had received.

Researchers say that stress gets less attention than diabetes, smoking, or high cholesterol even though it's just as important a risk factor in predicting who will have a cardiovascular event.

This week's top managed care stories include a lawsuit between Anthem and Express Scripts, trouble with Medicare's bidding program for diabetes test strips, and the cost of reporting quality measurements.

Data showed that patients coming to the world-famous hospital for a heart attack grew younger, sicker, and more obese from 1995 to 2014. Because the researchers have not yet reported socioeconomic status, it is hard to know whether the findings reflect broader trends.

Promoting healthier lifestyles, prevention, and population health are themes of the upcoming meeting of cardiologists in Chicago, which will take place April 2-4, 2016.

The randmized controlled trial confirms findings in observational studies that gastric bypass provides benefits beyond weight loss, and suggests BMI should not be the only consideration for who should have surgery. The fact that the study is associated with a major US payer is noteworthy.